Compugen (CGEN) Liabilities and Shareholders Equity (2009 - 2026)

Compugen's Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $145.9 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $145.9 million; the TTM figure through Mar 2026 stood at $417.4 million (up 26.3% YoY), while the FY2025 annual figure was $156.6 million, up 36.15% from the prior year.
• Liabilities and Shareholders Equity came in at $145.9 million for Q1 2026 at Compugen, down from $156.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $156.6 million in Q4 2025 to a low of $94.2 million in Q4 2022.
• A 5-year average of $126.6 million and a median of $121.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity retreated 28.74% in 2022 and soared 36.15% in 2025, its largest moves.
• Compugen's Liabilities and Shareholders Equity stood at $94.2 million in 2022, then gained by 28.84% to $121.3 million in 2023, then decreased by 5.22% to $115.0 million in 2024, then jumped by 36.15% to $156.6 million in 2025, then retreated by 6.84% to $145.9 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $145.9 million, $156.6 million, and $115.0 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison